Ankur Thomas

Ankur Thomas is a Senior Scientist at Biogen, with a career spanning over a decade focused on in vivo experiments, gene therapies, and various neurological disorders. Since October 2011, Ankur has held multiple roles, leading teams responsible for critical program data and supporting innovations in therapeutic modalities like viral gene therapies and biologics. Ankur's expertise also includes drug approval studies that contributed to the success of therapies such as Tecfidera. Prior positions include adjunct professorships at Quinnipiac University and the University of Hartford, and a Senior Associate Scientist role at Pfizer, where Ankur designed assays for neurodegeneration studies. Ankur holds both a Master's and Bachelor's degree in Physiology and Neurobiology from the University of Connecticut.